UT
United Therapeutics Corporation
UTHR· Health Care· BiotechnologyS&P 400
Close · 17/06/2026
551.47
1D
+0.58%52-week range
272.12 – 609.35
Volume
3,41,014.00
Price history
UTHR
18/05/2026 to 17/06/2026
O 549.35 H 555.92 L 547.01
1W+1.35%
1M-2.74%
3M+3.98%
6M+10.23%
1Y+91.11%
3Y+141.98%
5Y+205.54%
MAX+173.45%
Fundamentals
as of 17/06/2026- Market cap
- $23.65B
- Shares out
- 42.89M
- P/E (trailing)
- 18.04
- P/E (forward)
- 16.24
- EPS (trailing)
- 30.56
- Beta
- 0.56
- Profit margin
- 41.56%
- P/B
- 3.70
- Return on equity
- 20.48%
SEC financial statements
62 quarterly and 18 annual periods through 30/06/2026.
Details
- Ticker
- UTHR
- Index
- SP400
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 17/06/2026.
Tracked by Congress
1 filer · 0 on watchlist · 2 buys · 2 sells · R: 4
- 31/10/2025Lisa McClainSellUnited Therapeutics Corporation - Common Stock$1,001–$15,000
- 30/10/2025Lisa McClainBuyUnited Therapeutics Corporation - Common Stock$1,001–$15,000
- 30/10/2025Lisa McClainSellUnited Therapeutics Corporation - Common Stock$1,001–$15,000
- 11/06/2025Lisa McClainBuyUnited Therapeutics Corporation - Common Stock$1,001–$15,000